Home/Filings/4/0001437749-18-003127
4//SEC Filing

Kellen Scott 4

Accession 0001437749-18-003127

CIK 0001029125other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 5:28 PM ET

Size

6.6 KB

Accession

0001437749-18-003127

Insider Transaction Report

Form 4
Period: 2018-02-20
Kellen Scott
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-02-20+1,0004,500 total
  • Purchase

    Warrant (right to buy)

    2018-02-20+1,0001,000 total
    Exercise: $5.00From: 2018-02-20Exp: 2021-02-20Common Stock (1,000 underlying)
Footnotes (1)
  • [F1]Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $5.00 per "unit."

Issuer

Sun BioPharma, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001490476

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:28 PM ET
Size
6.6 KB